Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 864 in Teva Pharmaceutical Industries

  1. Abuse of U.S. generic-drug rules costs billions: reportRead the original story

    4 hrs ago | Reuters

    ... Inc, Perrigo Co Plc, Ranbaxy Laboratories Ltd, Sandoz Inc; Teva Americas, a unit of Teva Pharmaceutical Industries Ltd and Apotex Corp, among others. We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If ...

    Comment?

  2. George Soros Reveals His Largest StakeRead the original story

    5 hrs ago | GuruFocus.com

    ... 13-FA s fillings are in the health care and financial sectors. In this article, letA s see Teva Pharmaceutical Industries Limited ( TEVA ) in which the fund holds the largest stake in terms of market value. The fund disclosed a $544.8 million stake ...

    Comment?

  3. Drug Companies Are Manipulating The Rules At Your Expense: StudyRead the original story w/Photo

    6 hrs ago | Switched

    ... oratories Inc, Perrigo Co Plc, Ranbaxy Laboratories Ltd, Sandoz Inc; Teva Americas, a unit of Teva Pharmaceutical Industries Ltd and Apotex Corp, among others. (Reporting by Diane Bartz; Editing by Ros Krasny, Bernadette Baum and Andre Grenon)

    Comment?

  4. UPDATE 4-Biogen revenue trounces forecast as MS drug sales surgeRead the original story

    6 hrs ago | Reuters

    ... $300 million next year, as some patients switch from Avonex. Leading rival MS brands include Teva Pharmaceutical Industries Ltd's Copaxone and its newer version, which is taken less frequently. Biogen is conducting mid-stage trials of an MS drug ...

    Comment?

  5. Abuse of U.S. generic-drug rules costs billions -reportRead the original story

    7 hrs ago | AlertNet

    ... oratories Inc, Perrigo Co Plc, Ranbaxy Laboratories Ltd, Sandoz Inc; Teva Americas, a unit of Teva Pharmaceutical Industries Ltd and Apotex Corp, among others. (Reporting by Diane Bartz; Editing by Ros Krasny, Bernadette Baum and Andre Grenon)

    Comment?

  6. Some Teva Investors to Vote Against DirectorsRead the original story

    8 hrs ago | Wall Street Journal

    Some of the biggest shareholders of Teva Pharmaceutical Industries Ltd. aim to register their dissatisfaction with the pharmaceutical company's board by opposing the re-election of one or two members and other management proposals, according to people familiar with the investors' thinking.

    Comment?

  7. Analyst Update: EMC Corporation, Teva Pharmaceutical Industries Ltd...Read the original story

    9 hrs ago | SchaeffersResearch.com

    "I don't know another tech company that has [spun off one of its most strategic assets] and been successful," opined EMC CEO Joe Tucci in a conference call.

    Comment?

  8. Teva PharmaceuticalRead the original story w/Photo

    14 hrs ago | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  9. XTL Hopes To Begin Major Lupus Trial Next YearRead the original story

    Tuesday | Seeking Alpha

    ... journal articles published on hCDR1. The Weizmann Institute licensed the drug to Teva Pharmaceutical Industries, which conducted Phase 1a and 1b trials and the PRELUDE Phase 2 trial. The studies examined more than 400 patients, demonstrating that ...

    Comment?

  10. Antares Pharma Announces First Patient Dosed in Phase 3 QuickShot...Read the original story

    Tuesday | Freshnews

    ... multi-use pen injectors and reusable needle-free injectors marketed as Tjet and Zomajet by Teva Pharmaceutical Industries, Ltd (Teva) and Ferring Pharmaceuticals (Ferring), respectively. Antares Pharma has a multi-product deal with Teva that ...

    Comment?

  11. Safeguard Scientifics to Host Investor Day 2014 on October 15thRead the original story

    Tuesday | GlobeNewswire

    ... Crescendo Bioscience (acquired by Myriad Genetics for $270 million); NuPathe (acquired by Teva Pharmaceutical Industries for $144 million); and ThingWorx (acquired by PTC for initial proceeds of $112 million). For more information, please visit ...

    Comment?

  12. Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020Read the original story

    Tuesday | PR Log

    ... period. Key biosimilars developers such as Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., LG Life Sciences, Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec, Inc. and Genentech (Roche Group) ...

    Comment?

  13. Teva completes deal for second migraine-treatment developerRead the original story w/Photo

    Monday Jul 21 | Business Journal

    Teva Pharmaceutical Industries Ltd. completed its previously announced acquisition of Labrys in a deal that strengthens the generic and branded pharmaceutical company's presence in the migraine headache treatment and central nervous system disorder arena.

    Comment?

  14. Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014 - New Report AvailableRead the original story

    Monday Jul 21 | SBWire

    ... Mentioned in this Report: Amgen Inc., Reliance Life Sciences Pvt. Ltd., Richter Gedeon Nyrt., Teva Pharmaceutical Industries Limited, Sandoz Inc., Zosano Pharma, Inc., Jiangsu Hengrui Medicine Co., Ltd., Cellerant Therapeutics, Inc., Bolder ...

    Comment?

  15. Arena Pharmaceuticals, Inc. Enters Into Marketing And Supply...Read the original story

    Monday Jul 21 | BioSpace

    ... entered into an exclusive marketing and supply agreement for BELVIQA (lorcaserin HCl) with Teva Pharmaceutical Industries Limited's local Israeli subsidiary, Abic Marketing Limited. Under the agreement, Arena granted Abic the rights to market and ...

    Comment?

  16. Teva Pharmaceutical Industries Limited Completes Acquisition Of...Read the original story

    Monday Jul 21 | BioSpace

    Teva Pharmaceutical Industries Ltd. today announced the successful completion of the acquisition of Labrys.

    Comment?

  17. Arena subsidiary enters agreement with Israeli distributor for weight loss drugRead the original story

    Monday Jul 21 | San Diego Source

    Arena Pharmaceuticals Inc . announced on Monday that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement with Abic Marketing Limited, a Teva Pharmaceutical Industries subsidiary, for its weight loss and management product Belviq.

    Comment?

  18. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Monday Jul 21 | Business Wire

    ... to a Strong and Novel Migraine Prevention and Treatment Franchise within its CNS Portfolio )--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the successful completion of the acquisition of Labrys. The acquisition of Labrys brings to ...

    Comment?

  19. Teva Completes Acquisition of LabrysRead the original story w/Photo

    Monday Jul 21 | Pharmaceutical Processing

    Teva Pharmaceutical Industries Ltd. today announced the successful completion of the acquisition of Labrys.

    Comment?

  20. Arena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiaryRead the original story

    Monday Jul 7 | Theflyonthewall.com

    ... HCI product, Treanda, which is manufactured by Cephalon, Inc., a wholly-owned subsidiary of Teva Pharmaceutical Industries (TEVA), is a lyophilized powder requiring reconstitution and dilution in 500mL of saline or a sodium chloride / dextrose ...

    Comment?